Latest News about REPL
Recent news which mentions REPL
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
January 05, 2023
From Benzinga
Analyst Beefs Up Replimune Price Target As Recent Data Validates Treatment Platform
December 12, 2022
Tickers
REPL
From Benzinga
From Benzinga
Why Prometheus Biosciences Shares Are Trading Higher By Over 184%? Here Are 55 Stocks Moving In Wednesday's Mid-Day Session
December 07, 2022
From Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
December 07, 2022
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
December 07, 2022
From Benzinga
Replimune Gets 33% Price Target Bump Ahead Of Upcoming Readouts. Analyst Lists The Catalysts
October 14, 2022
From Benzinga
From Benzinga
Billionaires Are Scooping Up These 3 Beaten-Down Biotech Stocks
August 24, 2022
From Motley Fool
From Benzinga
From Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Friday
February 18, 2022
From Benzinga
The Daily Biotech Pulse: ImmunityBio Reports Positive Readout, Valneva Starts Late-Stage Chikungunya Vaccine Study, Sio Gene Shelves Parkinson's Program
February 01, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
January 20, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 19, 2021
November 19, 2021
From Benzinga
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
November 08, 2021
From Benzinga
10 Biggest Price Target Changes For Monday
August 23, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.